{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T19:24:55Z","timestamp":1780687495536,"version":"3.54.1"},"reference-count":83,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T00:00:00Z","timestamp":1675382400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNFSA170028392"],"award-info":[{"award-number":["NNFSA170028392"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010127","name":"J\u00fcrgen Manchot Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010127","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017790","name":"EPIC-XS","doi-asserted-by":"crossref","award":["823839"],"award-info":[{"award-number":["823839"]}],"id":[{"id":"10.13039\/100017790","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Biol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>In a range of human disorders such as multiple myeloma (MM), immunoglobulin light chains (IgLCs) can be produced at very high concentrations. This can lead to pathological aggregation and deposition of IgLCs in different tissues, which in turn leads to severe and potentially fatal organ damage. However, IgLCs can also be highly soluble and non-toxic. It is generally thought that the cause for this differential solubility behaviour is solely found within the IgLC amino acid sequences, and a variety of individual sequence-related biophysical properties (e.g. thermal stability, dimerisation) have been proposed in different studies as major determinants of the aggregation in vivo. Here, we investigate biophysical properties underlying IgLC amyloidogenicity.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We introduce a novel and systematic workflow, Thermodynamic and Aggregation Fingerprinting (ThAgg-Fip), for detailed biophysical characterisation, and apply it to nine different MM patient-derived IgLCs. Our set of pathogenic IgLCs spans the entire range of values in those parameters previously proposed to define in vivo amyloidogenicity; however, none actually forms amyloid in patients. Even more surprisingly, we were able to show that all our IgLCs are able to form amyloid fibrils readily in vitro under the influence of proteolytic cleavage by co-purified cathepsins.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>We show that (I) in vivo aggregation behaviour is unlikely to be mechanistically linked to any single biophysical or biochemical parameter and (II) amyloidogenic potential is widespread in IgLC sequences and is not confined to those sequences that form amyloid fibrils in patients. Our findings suggest that protein sequence, environmental conditions and presence and action of proteases all determine the ability of light chains to form amyloid fibrils in patients.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12915-022-01506-w","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T14:04:47Z","timestamp":1675433087000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Widespread amyloidogenicity potential of multiple myeloma patient-derived immunoglobulin light chains"],"prefix":"10.1186","volume":"21","author":[{"given":"Rebecca","family":"Sternke-Hoffmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pauly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasmus K.","family":"Norrild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Tucholski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus Haraldson","family":"H\u00f8ie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Marcatili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Dupr\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magalie","family":"Duchateau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martial","family":"Rey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Malosse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Metzger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Boquoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Platten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan U.","family":"Egelhaaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Chamot-Rooke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Fenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luitgard","family":"Nagel-Steger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1161-3622","authenticated-orcid":false,"given":"Alexander K.","family":"Buell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,3]]},"reference":[{"key":"1506_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-biochem-061516-045115","volume":"86","author":"F Chiti","year":"2017","unstructured":"Chiti F, Dobson CM. Protein misfolding, amyloid formation, and human disease: a summary of progress over the last decade. Annu Rev Biochem. 2017;86:27\u201368.","journal-title":"Annu Rev Biochem"},{"key":"1506_CR2","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","volume":"387","author":"AD Wechalekar","year":"2016","unstructured":"Wechalekar AD, Gillmore JD, Hawkins PN. Systemic amyloidosis. Lancet. 2016;387:2641\u201354.","journal-title":"Lancet"},{"key":"1506_CR3","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.1182\/blood.V80.9.2326.2326","volume":"80","author":"M Bakkus","year":"1992","unstructured":"Bakkus M, Heirman C, Van Riet I, Van Camp B, Thielemans K. Evidence that multiple myeloma Ig heavy chain VDJ genes contain somatic mutations but show no intraclonal variation. Blood. 1992;80:2326\u201335.","journal-title":"Blood"},{"key":"1506_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1084\/jem.116.2.207","volume":"116","author":"G Delman","year":"1962","unstructured":"Delman G, Gally J. The nature of Bence-Jones proteins: chemical similarities to polypeptide chains of myeloma globulins and normal \u03b3-globulins. J Exp Med. 1962;116:207\u201327.","journal-title":"J Exp Med"},{"key":"1506_CR5","doi-asserted-by":"publisher","first-page":"3869","DOI":"10.1182\/blood-2003-07-2501","volume":"103","author":"F Magrangeas","year":"2004","unstructured":"Magrangeas F, et al. Light-chain only multiple myeloma is due to the absence of functional (productive) rearrangement of the IgH gene at the DNA level. Blood. 2004;103:3869\u201375.","journal-title":"Blood"},{"key":"1506_CR6","doi-asserted-by":"publisher","first-page":"249","DOI":"10.5858\/133.2.249","volume":"133","author":"GA Herrera","year":"2009","unstructured":"Herrera GA. Renal lesions associated with plasma cell dyscrasias: practical approach to diagnosis, new concepts, and challenges. Arch Pathol Lab Med. 2009;133:249\u201367.","journal-title":"Arch Pathol Lab Med"},{"key":"1506_CR7","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1172\/JCI115629","volume":"89","author":"PW Sanders","year":"1992","unstructured":"Sanders PW, Booker BB. Pathobiology of cast nephropathy from human Bence Jones proteins. J Clin Invest. 1992;89:630\u20139.","journal-title":"J Clin Invest"},{"key":"1506_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/0002-9343(72)90063-0","volume":"52","author":"GG Glenner","year":"1972","unstructured":"Glenner GG, Ein D, Terry WD. The immunoglobulin origin of amyloid. Am J Med. 1972;52:141\u20137.","journal-title":"Am J Med"},{"key":"1506_CR9","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.bpc.2015.07.005","volume":"207","author":"Blancas-Mej.a, L. M.","year":"2015","unstructured":"Blancas-Mej.a, L. M., et al. Thermodynamic and fibril formation studies of full length immunoglobulin light chain AL-09 and its germline protein using scan rate dependent thermal unfolding. Biophys Chem. 2015;207:13\u201320.","journal-title":"Biophys Chem"},{"key":"1506_CR10","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1074\/jbc.M116.750323","volume":"292","author":"K Andrich","year":"2017","unstructured":"Andrich K, et al. Aggregation of full-length immunoglobulin light chains from systemic light chain amyloidosis (AL) patients is remodeled by epigallocatechin-3-gallate. J Biol Chem. 2017;292:2328\u201344.","journal-title":"J Biol Chem"},{"key":"1506_CR11","doi-asserted-by":"publisher","first-page":"19659","DOI":"10.1074\/jbc.RA118.004142","volume":"293","author":"B Brumshtein","year":"2018","unstructured":"Brumshtein B, et al. Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light-chain amyloidosis. J Biol Chem. 2018;293:19659\u201371.","journal-title":"J Biol Chem"},{"key":"1506_CR12","doi-asserted-by":"publisher","first-page":"4925","DOI":"10.1016\/j.jmb.2018.10.024","volume":"430","author":"B Weber","year":"2018","unstructured":"Weber B, et al. The antibody light-chain linker regulates domain orientation and amyloidogenicity. J Mol Biol. 2018;430:4925\u201340.","journal-title":"J Mol Biol"},{"key":"1506_CR13","doi-asserted-by":"publisher","first-page":"e8771","DOI":"10.7717\/peerj.8771","volume":"8","author":"R Sternke-Hoffmann","year":"2020","unstructured":"Sternke-Hoffmann R, et al. Biochemical and biophysical characterisation of immunoglobulin free light chains derived from an initially unbiased population of patients with light chain disease. PeerJ. 2020;8:e8771.","journal-title":"PeerJ"},{"key":"1506_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-16953-7","volume":"7","author":"L Oberti","year":"2017","unstructured":"Oberti L, et al. Concurrent structural and biophysical traits link with immunoglobulin light chains amyloid propensity. Sci Rep. 2017;7:1\u201311.","journal-title":"Sci Rep"},{"key":"1506_CR15","doi-asserted-by":"publisher","first-page":"9848","DOI":"10.1021\/bi101351c","volume":"49","author":"ES Klimtchuk","year":"2010","unstructured":"Klimtchuk ES, et al. The critical role of the constant region in thermal stability and aggregation of amyloidogenic immunoglobulin light chain. Biochemistry. 2010;49:9848\u201357.","journal-title":"Biochemistry"},{"key":"1506_CR16","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.1111\/febs.12538","volume":"280","author":"Gonz.lez-Andrade, M.","year":"2013","unstructured":"Gonz.lez-Andrade, M., et al. Mutational and genetic determinants of \u03bb6 light chain amyloidogenesis. FEBS J. 2013;280:6173\u201383.","journal-title":"FEBS J"},{"key":"1506_CR17","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.2174\/1568026611212220007","volume":"12","author":"M Ramirez-Alvarado","year":"2012","unstructured":"Ramirez-Alvarado M. Amyloid formation in light chain amyloidosis. Curr Top Med Chem. 2012;12:2523\u201333.","journal-title":"Curr Top Med Chem"},{"key":"1506_CR18","doi-asserted-by":"publisher","first-page":"14101","DOI":"10.1021\/bi991131j","volume":"38","author":"J Wall","year":"1999","unstructured":"Wall J, et al. Thermodynamic instability of human \u03bb6 light chains: correlation with fibrillogenicity. Biochemistry. 1999;38:14101\u20138.","journal-title":"Biochemistry"},{"key":"1506_CR19","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1074\/jbc.275.3.1570","volume":"275","author":"YS Kim","year":"2000","unstructured":"Kim YS, et al. Thermodynamic modulation of light chain amyloid fibril formation. J Biol Chem. 2000;275:1570\u20134.","journal-title":"J Biol Chem"},{"key":"1506_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/bjh.15387","volume":"182","author":"ME Gatt","year":"2018","unstructured":"Gatt ME, et al. The use of serum free light chain dimerization patterns assist in the diagnosis of al amyloidosis. Br J Haematol. 2018;182:86\u201392.","journal-title":"Br J Haematol"},{"key":"1506_CR21","doi-asserted-by":"publisher","first-page":"3521","DOI":"10.1021\/bi061716v","volume":"46","author":"Z Qin","year":"2007","unstructured":"Qin Z, Hu D, Zhu M, Fink AL. Structural characterization of the partially folded intermediates of an immunoglobulin light chain leading to amyloid fibrillation and amorphous aggregation. Biochemistry. 2007;46:3521\u201331.","journal-title":"Biochemistry"},{"key":"1506_CR22","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1002\/ajh.23773","volume":"89","author":"B Kaplan","year":"2014","unstructured":"Kaplan B, et al. Immunoglobulin-free light chain monomer-dimer patterns help to distinguish malignant from premalignant monoclonal gammopathies: a pilot study. Am J Hematol. 2014;89:882\u20138.","journal-title":"Am J Hematol"},{"key":"1506_CR23","doi-asserted-by":"publisher","first-page":"30950","DOI":"10.1074\/jbc.M804822200","volume":"283","author":"EM Baden","year":"2008","unstructured":"Baden EM, Randles EG, Aboagye AK, Thompson JR, Ramirez-Alvarado M. Structural insights into the role of mutations in amyloidogenesis. J Biol Chem. 2008;283:30950\u20136.","journal-title":"J Biol Chem"},{"key":"1506_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-10906-w","volume":"7","author":"S Mukherjee","year":"2017","unstructured":"Mukherjee S, Pondaven SP, Hand K, Madine J, Jaroniec CP. Effect of amino acid mutations on the conformational dynamics of amyloidogenic immunoglobulin light-chains: a combined NMR and in silico study. Sci Rep. 2017;7:1\u201313.","journal-title":"Sci Rep"},{"key":"1506_CR25","first-page":"409","volume":"1864","author":"ML Wolwertz","year":"2016","unstructured":"Wolwertz ML, Nguyen PT, Quittot N, Bourgault S. Probing the role of \u03bb6 immunoglobulin light chain dimerization in amyloid formation. Biochimica et Biophys. 2016;1864:409\u201318.","journal-title":"Biochimica et Biophys"},{"key":"1506_CR26","volume-title":"The immunoglobulin factsbook","author":"M-P Lefranc","year":"2001","unstructured":"Lefranc M-P, Lefranc G. The immunoglobulin factsbook: Academic press; 2001."},{"key":"1506_CR27","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/nri1896","volume":"6","author":"VH Odegard","year":"2006","unstructured":"Odegard VH, Schatz DG. Targeting of somatic hypermutation. Nat Rev Immunol. 2006;6:573\u201383.","journal-title":"Nat Rev Immunol"},{"key":"1506_CR28","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1084\/jem.155.5.1480","volume":"155","author":"OW McBride","year":"1982","unstructured":"McBride OW, et al. Chromosomal location of human kappa and lambda immunoglobulin light chain constant region genes. J Exp Med. 1982;155:1480\u201390.","journal-title":"J Exp Med"},{"key":"1506_CR29","doi-asserted-by":"publisher","first-page":"4957","DOI":"10.1073\/pnas.79.16.4957","volume":"79","author":"S Malcolm","year":"1982","unstructured":"Malcolm S, et al. Localization of human immunoglobulin kappa light chain variable region genes to the short arm chromosome 2 by in situ hybridization. Proc Natl Acad Sci. 1982;79:4957\u201361.","journal-title":"Proc Natl Acad Sci"},{"key":"1506_CR30","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1056\/NEJM197402282900902","volume":"290","author":"T Isobe","year":"1974","unstructured":"Isobe T, Osserman EF. Patterns of amyloidosis and their association with plasma-cell dyscrasia, monoclonal immunoglobulins and Bence-Jones proteins. New Engl J Med. 1974;290:473\u20137.","journal-title":"New Engl J Med"},{"key":"1506_CR31","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1182\/blood-2016-10-743997","volume":"129","author":"TV Kourelis","year":"2017","unstructured":"Kourelis TV, et al. Clarifying immunoglobulin gene usage in systemic and localized immunoglobulin light- amyloidosis by mass spectrometry. Blood. 2017;129:299\u2013306.","journal-title":"Blood"},{"key":"1506_CR32","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1182\/blood-2002-01-0114","volume":"100","author":"V Perfetti","year":"2002","unstructured":"Perfetti V, et al. Analysis of v\u03bb-j\u03bb expression in plasma cells from primary (al) amyloidosis and normal bone marrow identifies 3r (\u03bbiii) as a new amyloid-associated germline gene segment. Blood. 2002;100:948.","journal-title":"Blood"},{"key":"1506_CR33","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1038\/nature09837","volume":"471","author":"MA Chapman","year":"2011","unstructured":"Chapman MA, et al. Initial genome sequencing and analysis of multiple myeloma. Nature. 2011;471:467\u201372.","journal-title":"Nature"},{"key":"1506_CR34","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1021\/jasms.0c00036","volume":"31","author":"K Srzentic","year":"2020","unstructured":"Srzentic K, et al. Interlaboratory study for characterizing monoclonal antibodies by top-down and middle-down mass spectrometry. J Am Soc Mass Spectrom. 2020;31:1783\u2013802.","journal-title":"J Am Soc Mass Spectrom"},{"key":"1506_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep31730","volume":"6","author":"NH Tran","year":"2016","unstructured":"Tran NH, et al. Complete de novo assembly of monoclonal antibody sequences. Sci Rep. 2016;6:1\u201310.","journal-title":"Sci Rep"},{"key":"1506_CR36","doi-asserted-by":"crossref","unstructured":"Dupr\u00e9., M., et al. Optimization of a top-down proteomics platform for closely related pathogenic bacterial discrimination. J. Proteome Res. 2020.","DOI":"10.1021\/acs.jproteome.0c00351"},{"key":"1506_CR37","doi-asserted-by":"publisher","first-page":"10627","DOI":"10.1021\/acs.analchem.1c01955","volume":"93","author":"Dupr\u00e9., M.","year":"2021","unstructured":"Dupr\u00e9., M., et al. De novo sequencing of antibody light chain proteoforms from patients with multiple myeloma. Anal Chem. 2021;93:10627\u201334.","journal-title":"Anal Chem"},{"key":"1506_CR38","doi-asserted-by":"publisher","first-page":"7934","DOI":"10.1038\/s41598-018-26338-z","volume":"8","author":"P Kunz","year":"2018","unstructured":"Kunz P, et al. The structural basis of nanobody unfolding reversibility and thermoresistance. Sci Rep. 2018;8:7934.","journal-title":"Sci Rep"},{"key":"1506_CR39","doi-asserted-by":"publisher","first-page":"18976","DOI":"10.1073\/pnas.0705127104","volume":"104","author":"L Stagg","year":"2007","unstructured":"Stagg L, Zhang S-Q, Cheung MS, Wittung-Stafshede P. Molecular crowding enhances native structure and stability of \u03b1\/\u03b2 protein flavodoxin. Proc Nat Ac Sc. 2007;104:18976\u201381.","journal-title":"Proc Nat Ac Sc"},{"key":"1506_CR40","doi-asserted-by":"publisher","first-page":"113863","DOI":"10.1016\/j.ab.2020.113863","volume":"605","author":"L Hamborg","year":"2020","unstructured":"Hamborg L, et al. Global analysis of protein stability by temperature and chemical denaturation. Anal Biochem. 2020;605:113863.","journal-title":"Anal Biochem"},{"key":"1506_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0003-9861(59)90016-5","volume":"83","author":"FW Putnam","year":"1959","unstructured":"Putnam FW, Easley CW, Lynn LT, Ritchie AE, Phelps RA. The heat precipitation of Bence-Jones proteins. I. optimum conditions. Arch Biochem Biophys. 1959;83:115\u20133.","journal-title":"Arch Biochem Biophys"},{"key":"1506_CR42","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1021\/acsnano.5b04713","volume":"10","author":"P Arosio","year":"2015","unstructured":"Arosio P, et al. Microfluidic diffusion analysis of the sizes and interactions of proteins under native solution conditions. ACS Nano. 2015;10:333\u201341.","journal-title":"ACS Nano"},{"key":"1506_CR43","first-page":"68","volume":"1824","author":"V Turk","year":"2012","unstructured":"Turk V, et al. Cysteine cathepsins: from structure, function and regulation to new frontiers. Biochimica et Biophys. 2012;1824:68\u201388.","journal-title":"Biochimica et Biophys"},{"key":"1506_CR44","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1593\/neo.08178","volume":"10","author":"I Giusti","year":"2008","unstructured":"Giusti I, et al. Cathepsin B mediates the pH-dependent proinvasive activity of tumor-shed microvesicles. Neoplasia. 2008;10:481\u20138.","journal-title":"Neoplasia"},{"key":"1506_CR45","doi-asserted-by":"publisher","first-page":"16816","DOI":"10.1074\/jbc.273.27.16816","volume":"273","author":"I Santamar","year":"1998","unstructured":"Santamar I, Velasco G, Pend\u00e1s AM, Fueyo A, L\u00f3pez-Ot\u0131n C, Cathepsin Z. A novel human cysteine proteinase with a short propeptide domain and a unique chromosomal location. J Biol Chem. 1998;273:16816\u201323.","journal-title":"J Biol Chem"},{"key":"1506_CR46","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1471-4159.1991.tb03767.x","volume":"57","author":"J Whitaker","year":"1991","unstructured":"Whitaker J, Herman P, Sparacio S, Zhou S, Benveniste E. Changes induced in astrocyte cathepsin D by cytokines and leupeptin. J Neurochem. 1991;57:406\u201314.","journal-title":"J Neurochem"},{"key":"1506_CR47","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1111\/j.1742-4658.2011.08207.x","volume":"278","author":"A Chailyan","year":"2011","unstructured":"Chailyan A, Marcatili P, Tramontano A. The association of heavy and light chain variable domains in antibodies: implications for antigen specificity. FEBS J. 2011;278:2858\u201366.","journal-title":"FEBS J"},{"key":"1506_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-09032-0","volume":"10","author":"L Radamaker","year":"2019","unstructured":"Radamaker L, et al. Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis. Nat Commun. 2019;10:1\u20138.","journal-title":"Nat Commun"},{"key":"1506_CR49","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/s41467-019-09133-w","volume":"10","author":"P Swuec","year":"2019","unstructured":"Swuec P, et al. Cryo-em structure of cardiac amyloid fibrils from an immunoglobulin light chain al amyloidosis patient. Nat Commun. 2019;10:1269.","journal-title":"Nat Commun"},{"key":"1506_CR50","doi-asserted-by":"publisher","first-page":"16572","DOI":"10.1074\/jbc.RA120.013461","volume":"295","author":"F Lavatelli","year":"2020","unstructured":"Lavatelli F, et al. Mass spectrometry characterization of light chain fragmentation sites in cardiac AL amyloidosis: insights into the timing of proteolysis. J Biol Chem. 2020;295:16572\u201384.","journal-title":"J Biol Chem"},{"key":"1506_CR51","doi-asserted-by":"publisher","first-page":"6200","DOI":"10.1073\/pnas.1522282113","volume":"113","author":"A Schmidt","year":"2016","unstructured":"Schmidt A, Annamalai K, Schmidt M, Grigorieff N, F\u00e4ndrich M. Cryo-EM reveals the steric zipper structure of a light chain-derived amyloid fibril. Proc Natl Acad Sci. 2016;113:6200\u20135.","journal-title":"Proc Natl Acad Sci"},{"key":"1506_CR52","first-page":"473","volume":"219","author":"S Enqvist","year":"2009","unstructured":"Enqvist S, Sletten K, Westermark P. Fibril protein fragmentation pattern in systemic AL-amyloidosis. J Pathol A J Pathol Soc Gt Br Irel. 2009;219:473\u201380.","journal-title":"J Pathol A J Pathol Soc Gt Br Irel"},{"key":"1506_CR53","first-page":"863","volume":"368","author":"M Eulitz","year":"1987","unstructured":"Eulitz M, Breuer M, Linke RP. Is the formation of AL-type amyloid promoted by structural peculiarities of immunoglobulin L-chains? Primary structure of an amyloidogenic \u03bb-L-chain (BJP-ZIM). Biol Chem. 1987;368:863\u201370.","journal-title":"Biol Chem"},{"key":"1506_CR54","doi-asserted-by":"publisher","first-page":"10697","DOI":"10.1021\/bi00034a001","volume":"34","author":"FJ Stevens","year":"1995","unstructured":"Stevens FJ, et al. A molecular model for self-assembly of amyloid fibrils: immunoglobulin light chains. Biochem. 1995;34:10697\u2013702.","journal-title":"Biochem"},{"key":"1506_CR55","doi-asserted-by":"publisher","first-page":"3487","DOI":"10.1073\/pnas.0915166107","volume":"107","author":"L Goldschmidt","year":"2010","unstructured":"Goldschmidt L, Teng PK, Riek R, Eisenberg D. Identifying the amylome, proteins capable of forming amyloid-like fibrils. Proc Nat Acad Sc. 2010;107:3487\u2013349.","journal-title":"Proc Nat Acad Sc"},{"key":"1506_CR56","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nmeth.1432","volume":"7","author":"S Maurer-Stroh","year":"2010","unstructured":"Maurer-Stroh S, et al. Exploring the sequence determinants of amyloid structure using position-specific scoring matrices. Nat Methods. 2010;7:237\u201342.","journal-title":"Nat Methods"},{"key":"1506_CR57","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/nbt1012","volume":"22","author":"A-M Fernandez-Escamilla","year":"2004","unstructured":"Fernandez-Escamilla A-M, Rousseau F, Schymkowitz J, Serrano L. Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins. Nat Biotech. 2004;22:1302\u20136.","journal-title":"Nat Biotech"},{"key":"1506_CR58","doi-asserted-by":"publisher","first-page":"W301","DOI":"10.1093\/nar\/gku399","volume":"42","author":"I Walsh","year":"2014","unstructured":"Walsh I, Seno F, Tosatto SC, Trovato A. PASTA 2.0: an improved server for protein aggregation prediction. Nucl Ac Res. 2014;42:W301\u20137.","journal-title":"Nucl Ac Res"},{"key":"1506_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/13506120802676781","volume":"16","author":"K Bodi","year":"2009","unstructured":"Bodi K, et al. AL-base: a visual platform analysis tool for the study of amyloidogenic immunoglobulin light chain sequences. Amyloid. 2009;16:1\u20138.","journal-title":"Amyloid"},{"key":"1506_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-021-93019-9","volume":"11","author":"P Rawat","year":"2021","unstructured":"Rawat P, Prabakaran R, Kumar S, Gromiha MM. Exploring the sequence features determining amyloidosis in human antibody light chains. Sci Rep. 2021;11:1\u201311.","journal-title":"Sci Rep"},{"key":"1506_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-23880-9","volume":"12","author":"M Garofalo","year":"2021","unstructured":"Garofalo M, et al. Machine learning analyses of antibody somatic mutations predict immunoglobulin light chain toxicity. Nat Commun. 2021;12:1\u201310.","journal-title":"Nat Commun"},{"key":"1506_CR62","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1110\/ps.8.3.509","volume":"8","author":"R Raffen","year":"1999","unstructured":"Raffen R, et al. Physicochemical consequences of amino acid variations that contribute to fibril formation by immunoglobulin light chains. Protein Sci. 1999;8:509\u201317.","journal-title":"Protein Sci"},{"key":"1506_CR63","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jmb.2009.11.038","volume":"396","author":"A Hern\u00e1ndez-Santoyo","year":"2010","unstructured":"Hern\u00e1ndez-Santoyo A, et al. A single mutation at the sheet switch region results in conformational changes favoring \u03bb6 light-chain fibrillogenesis. J Mol Biol. 2010;396:280\u201392.","journal-title":"J Mol Biol"},{"key":"1506_CR64","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1002\/prot.10606","volume":"55","author":"M Nowak","year":"2004","unstructured":"Nowak M. Immunoglobulin kappa light chain and its amyloidogenic mutants: a molecular dynamics study. Proteins. 2004;55:11\u201321.","journal-title":"Proteins"},{"key":"1506_CR65","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/200223b0","volume":"200","author":"GM Bernier","year":"1963","unstructured":"Bernier GM, Putnam FW. Monomer\u2013dimer forms of Bence Jones proteins. Nature. 1963;200:223\u20135.","journal-title":"Nature"},{"key":"1506_CR66","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1042\/bj3630417","volume":"363","author":"CS Pillay","year":"2002","unstructured":"Pillay CS, Elliott E, Dennison C. Endolysosomal proteolysis and its regulation. Biochem J. 2002;363:417\u201329.","journal-title":"Biochem J"},{"key":"1506_CR67","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1159\/000330487","volume":"35","author":"N Nakanishi","year":"2012","unstructured":"Nakanishi N, et al. Low urine pH is a predictor of chronic kidney disease. Kidney Blood Press Res. 2012;35:77\u201381.","journal-title":"Kidney Blood Press Res"},{"key":"1506_CR68","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1046\/j.1365-2141.1999.01778.x","volume":"107","author":"A Rostagno","year":"1999","unstructured":"Rostagno A, et al. pH-dependent fibrillogenesis of a V\u03baIII Bence Jones protein. Brit J Haematol. 1999;107:835\u201343.","journal-title":"Brit J Haematol"},{"key":"1506_CR69","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3109\/13506129809007296","volume":"5","author":"J Isaac","year":"1998","unstructured":"Isaac J, et al. In vitro modulation of al-amyloid formation by human mesangial cells exposed to amyloidogenic light chains. Amyloid. 1998;5:238\u201346.","journal-title":"Amyloid"},{"key":"1506_CR70","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/labinvest.3700161","volume":"84","author":"J Keeling","year":"2004","unstructured":"Keeling J, Teng J, Herrera GA. Al-amyloidosis and light-chain deposition disease light chains induce divergent phenotypic transformations of human mesangial cells. Lab Invest. 2004;84:1322\u201338.","journal-title":"Lab Invest"},{"key":"1506_CR71","doi-asserted-by":"publisher","first-page":"8360","DOI":"10.1073\/pnas.1817567116","volume":"116","author":"GJ Morgan","year":"2019","unstructured":"Morgan GJ, et al. Stabilization of amyloidogenic immunoglobulin light chains by small molecules. Proc Natl Acad Sci. 2019;116:8360\u20139.","journal-title":"Proc Natl Acad Sci"},{"key":"1506_CR72","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/00031305.1983.10482729","volume":"37","author":"DA Freedman","year":"1983","unstructured":"Freedman DA. A note on screening regression equations. Am Stat. 1983;37:152\u20135.","journal-title":"Am Stat"},{"key":"1506_CR73","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/S0006-3495(00)76713-0","volume":"78","author":"P Schuck","year":"2000","unstructured":"Schuck P. Size-distribution analysis of macromolecules by sedimentation velocity ultracentrifugation and lamm equation modeling. Biophys J. 2000;78:1606\u201319.","journal-title":"Biophys J"},{"key":"1506_CR74","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1529\/biophysj.106.081372","volume":"90","author":"PH Brown","year":"2006","unstructured":"Brown PH, Schuck P. Macromolecular size-and-shape distributions by sedimentation velocity analytical ultracentrifugation. Biophys J. 2006;90:4651\u201361.","journal-title":"Biophys J"},{"key":"1506_CR75","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1002\/pro.3170","volume":"26","author":"G \u017dold\u00e1k","year":"2017","unstructured":"\u017dold\u00e1k G, Jancura D, Sedl\u00e1k E. The fluorescence intensities ratio is not a reliable parameter for evaluation of protein unfolding transitions. Protein Sci. 2017;26:1236\u20139.","journal-title":"Protein Sci"},{"key":"1506_CR76","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1093\/protein\/gzaa010","volume":"32","author":"K Lindorff-Larsen","year":"2019","unstructured":"Lindorff-Larsen K. Dissecting the statistical properties of the linear extrapolation method of determining protein stability. Protein Eng Des Sel. 2019;32:471\u20139.","journal-title":"Protein Eng Des Sel"},{"key":"1506_CR77","doi-asserted-by":"publisher","first-page":"6036","DOI":"10.1021\/bi002555c","volume":"40","author":"L Nielsen","year":"2001","unstructured":"Nielsen L, et al. Effect of environmental factors on the kinetics of insulin fibril formation: elucidation of the molecular mechanism. Biochemistry. 2001;40:6036\u201346.","journal-title":"Biochemistry"},{"key":"1506_CR78","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1038\/nchem.2344","volume":"7","author":"EV Yates","year":"2015","unstructured":"Yates EV, et al. Latent analysis of unmodified biomolecules and their complexes in solution with attomole detection sensitivity. Nat Chem. 2015;7:802\u20139.","journal-title":"Nat Chem"},{"key":"1506_CR79","doi-asserted-by":"publisher","first-page":"W349","DOI":"10.1093\/nar\/gkv535","volume":"43","author":"MS Klausen","year":"2015","unstructured":"Klausen MS, Anderson MV, Jespersen MC, Nielsen M, Marcatili P. LYRA, a webserver for lymphocyte receptor structural modeling. Nucleic Acids Res. 2015;43:W349\u201355.","journal-title":"Nucleic Acids Res"},{"key":"1506_CR80","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-1-4939-9752-7_15","volume":"2053","author":"G Bitencourt-Ferreira","year":"2019","unstructured":"Bitencourt-Ferreira G, de Azevedo WF. Homology modeling of protein targets with MODELLER. Methods Mol. Biol. (Clifton, N.J.). 2019;2053:231\u201349. https:\/\/doi.org\/10.1007\/978-1-4939-9752-7_15.","journal-title":"Methods Mol. Biol. (Clifton, N.J.)"},{"key":"1506_CR81","volume-title":"PyMOL","author":"L Schr\u00f6dinger","year":"2020","unstructured":"Schr\u00f6dinger L, DeLano W. PyMOL; 2020."},{"key":"1506_CR82","doi-asserted-by":"publisher","first-page":"D624","DOI":"10.1093\/nar\/gkx1134","volume":"46","author":"ND Rawlings","year":"2018","unstructured":"Rawlings ND, et al. The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database. Nucleic Acids Res. 2018;46:D624\u201332. https:\/\/doi.org\/10.1093\/nar\/gkx1134.","journal-title":"Nucleic Acids Res"},{"key":"1506_CR83","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1093\/bioinformatics\/btp163","volume":"25","author":"PJA Cock","year":"2009","unstructured":"Cock PJA, et al. Biopython: freely available Python tools for computational molecular biology and bioinformatics. Bioinformatics. 2009;25:1422\u20133. https:\/\/doi.org\/10.1093\/bioinformatics\/btp163.","journal-title":"Bioinformatics"}],"container-title":["BMC Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-022-01506-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12915-022-01506-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12915-022-01506-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T15:38:31Z","timestamp":1728833911000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbiol.biomedcentral.com\/articles\/10.1186\/s12915-022-01506-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,3]]},"references-count":83,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1506"],"URL":"https:\/\/doi.org\/10.1186\/s12915-022-01506-w","relation":{},"ISSN":["1741-7007"],"issn-type":[{"value":"1741-7007","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,3]]},"assertion":[{"value":"22 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients from whom samples were taken for this study have given their consent that the results of this study can be published (study number 5926R and registration ID 20170664320).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21"}}